Graves' disease
RecruitingStudy of IMVT-1402 Treatment for Adults with Graves' Disease
- Disease:Graves' disease
- Substances:IMEROPRUBART
Bulgaria- Participants:18–64 years · 65+ years
- Substances:IMEROPRUBART
- Sponsor:Immunovant Sciences GmbH
Rare diseases
Investigational molecules
Locations
Back to Bulgaria37 clinical trials in Yambol, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on heart failure and atrial fibrillation, evaluating new therapeutic combinations and preventive treatments.
Advanced trials exploring combination therapies with empagliflozin and innovative anticoagulation approaches.
Comprehensive research into Type 2 Diabetes and obesity management, including studies on weight reduction and glycemic control.
Investigating weekly insulin alternatives and innovative weight loss interventions.
Studies examining treatments for COPD and chronic urticaria, evaluating both established and experimental therapies.
Testing advanced inhalation therapies and targeted immunological treatments.
Investigation of treatments for chronic kidney disease with concurrent hypertension, focusing on disease progression prevention.
Evaluating innovative drug combinations to slow CKD progression.
Tell us about your condition – we search every trial in Europe and connect you with the right site.